logo
Select company
Select metric
0.26%Gross Profits to Assets
VS
Market
14
Sector
35
Industry
52
History
12
$ 9.42Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Gross Profits to Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - GPA Historical data
DateTotal AssetsGross ProfitGross Profits to Assets
6/30/2025$ 388.89M$ 1.03M0.26%
3/31/2025$ 409.13M$ 34.17M8.35%
12/31/2024$ 435.02M$ 38.91M8.95%
9/30/2024$ 455.32M$ 47.94M10.53%
6/30/2024$ 347.74M$ 54.1M15.56%
3/31/2024$ 325.21M$ 25.91M7.97%
12/31/2023$ 305.05M$ 26M8.52%
9/30/2023$ 106.03M$ 34.53M32.57%
6/30/2023$ 139.51M$ 48.69M34.9%
3/31/2023$ 155.69M$ 82.72M53.13%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) GPA stands at 6.24%.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average GPA has been 30.53%.
  • The median GPA for CARTESIAN THERAPEUTICS INC during this period was 20.92%
  • CARTESIAN THERAPEUTICS INC reached its highest GPA over the past 5 years at 74.14%.
  • The lowest GPA recorded by CARTESIAN THERAPEUTICS INC in the same timeframe 0.26%

CARTESIAN THERAPEUTICS INC's GPA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GPA Benchmarks
CompanyGPA
HUMA : HUMACYTE INC 0.33%NWBO : NORTHWEST BIOTHERAPEUTICS INC 3.7%MREO : MEREO BIOPHARMA GROUP PLC 0.59%INBX : INHIBRX BIOSCIENCES INC 0.66%CRDF : CARDIFF ONCOLOGY INC 0.72%BTAI : BIOXCEL THERAPEUTICS INC -4.87%CATX : PERSPECTIVE THERAPEUTICS INC 0.4%ADVM : ADVERUM BIOTECHNOLOGIES INC 1.04%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC 48.65%LSTA : LISATA THERAPEUTICS INC 4.25%

Definition of Gross Profits to Assets

[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
GP / Assets
(=) GPA
GPA for CARTESIAN THERAPEUTICS INC is calculated as follows: GP [ $ 11.3M ] / Assets [ $ 181M ]
(=) GPA [ 6.24% ]

RNAC - Gross Profits to Assets, Last 5 years

0.26%

Minimum

Jun 30, 2025

74.14%

Maximum

Mar 31, 2022

30.53%

Average

20.92%

Median

GPA Benchmark Analysis

The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.16% with a standard deviation of 19.94%.
The following table provides additional summary stats:
GPA in the Market:
filtered constituents4.13K
min-50.32%
max83.98%
average20.16%
median15.35%
std19.94%